The exercise period for Acarix warrants of series 2022:U begins today
In December 2022, Acarix AB (publ) (“Acarix” or the “Company”) carried out a rights issue of shares and warrants of series 2022:U (the ...
The exercise period for Acarix warrants of series 2022:U begins today
In December 2022, Acarix AB (publ) (“Acarix” or the “Company”) carried out a rights issue of shares and warrants of series 2022:U (the ...
Acarix to present at the 2023 Aktiespararna Share Day in Stockholm
Acarix will present at the 2023 Aktiespararna Share Day in Stockholm on May 3, 2023Nine CEOs, including Acarix CEO Helen Ljungdahl Roun...
Acarix AB’s Årsredovisning 2022
Acarix, ledare inom akustisk och AI-baserad hjärtdiagnostik, meddelar idag att årsredovisning för 2022 finns tillgänglig som pdf på bol...
Acarix AB’s Annual Report 2022
Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announces that the Annual Report for 2022 is available as a pdf on...
Acarix AB Annual Report 2022
Acarix, a leader in acoustic and AM-based cardiac diagnostics, today announces that the Annual Rport for 2022 is available as a pdf on ...
Kallelse till årsstämma i Acarix AB
Aktieägarna i Acarix AB, org.nr 559009-0667, ("Bolaget") kallas härmed till årsstämma torsdagen den 11 maj 2023 klockan 10.00...
Notice of Annual General Meeting in Acarix AB
The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby convened to the annual general meeting to be...
Notice of Annual General Meeting in Acarix AB
The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby convened to the annual general meeting to be...
Study published in Heart strengthens diagnostic value of Acarix CADScor System
The study confirms that the CADScor System has a very high rule-out accuracy in low-risk patients with chest pains, and potential to re...
Acarix genomför en riktad nyemission om cirka 9,5 MSEK
DETTA PRESSMEDDELANDE ÄR EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARKEN DIREKT ELLER INDIREKT, INOM ELLER TILL USA, AU...
Acarix carries out a directed share issue amounting to approximately SEK 9.5 million
THIS PRESS RELEASE IS NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, ...